Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial

EU Horizon 2020 (grant agreement No. 825319); Cicely Saunders International Breathlessness Programme; National Institute for Health and Care Research Applied Research Collaboration South London; Australian National Health and Medical Research Council-EU (application ID: APP1170731).

Authors

Institutions

Publication Details

Journal
The Lancet Respiratory Medicine
Published
2024-09-09
DOI
https://doi.org/10.1016/s2213-2600(24)00187-5
Citations
20
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
8.38
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial

Sabrina Bajwah, Claudia Bausewein, Peter May, David C. Currow et al.
20 citations
The Lancet Respiratory Medicine
Chronic Obstructive Pulmonary Disease (COPD) Research
8.38
article

Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial

Sabrina Bajwah, Claudia Bausewein, Peter May, David C. Currow, Matthew M Maddocks, Simon P. Hart, Piotr Janowiak, Andrew Wilcock, Caroline J. Jolley, Silvia Tanzi, Julia Brown, Charles Normand, Massimo Costantini, Małgorzata Krajnik, H M Mather, Charlotte E. Bolton, Elena Turola, Steffen T. Simon, Luca Ghirotto, Miriam J. Johnson, Bobbie Farsides, Adejoke O Oluyase, Geraldine Murden, Irene J Higginson, Karen Ryan, Sarah T Brown
article en
20 citations

Abstract

EU Horizon 2020 (grant agreement No. 825319); Cicely Saunders International Breathlessness Programme; National Institute for Health and Care Research Applied Research Collaboration South London; Australian National Health and Medical Research Council-EU (application ID: APP1170731).

The Lancet Respiratory MedicineVol. 12(10)
Brighton and Sussex Medical School (GB), University of Leeds (GB), Nottingham University Hospitals NHS Trust (GB), University of Nottingham (GB), University of Sussex (GB), King's College London (GB), University of Hull (GB), University of Wollongong (AU), Mater Misericordiae University Hospital (IE), Nicolaus Copernicus University (PL), University of Gdańsk (PL), Düsseldorf University Hospital (DE), Azienda Sanitaria Unità Locale di Reggio Emilia (IT), Integrated Oncology (United States) (US), Cicely Saunders International (GB), Nottingham Biomedical Research Centre (GB), Collegium Medicum in Bydgoszcz (PL), Istituti di Ricovero e Cura a Carattere Scientifico (IT), University Hospital Cologne (DE), Heinrich Heine University Düsseldorf (DE), Hull York Medical School (GB), Gdańsk Medical University (PL), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 2%
Chronic Obstructive Pulmonary Disease (COPD) Research
8.38
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.